Fangxuan Li

8PUBLICATIONS
8CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 04, 2024
Comparison of MRI and Ultrasound for Evaluation of Axillary Lymph Node Status in Early Breast Cancer.

Ling Li, Jing Zhao, Fangxuan Li

|Jan 20, 2021
High Risk Thyroid Nodule Discrimination and Management by Modified TI-RADS.

Menghui Li, Lijuan Wei, Fangxuan Li

|Sep 11, 2020
UBR5 over-expression contributes to poor prognosis and tamoxifen resistance of ERa+ breast cancer by stabilizing β-catenin.

Yanfang Yang, Jing Zhao, Yiran Mao

|Dec 18, 2019
Chemoresistance was correlated with elevated expression and activity of indoleamine 2,3-dioxygenase in breast cancer.

Yang Zhao, Lijuan Wei, Juntian Liu

Pageof 2